What is CAR T-cell Therapy?

Also known as: chimeric antigen receptor T-cell therapy, Kymriah.

Nicklaus Children’s Hospital is now offering cutting-edge immune effector cell therapy for children and young adults with leukemia and lymphoma.

One of these treatments, known as chimeric antigen receptor T-cell (CAR T-cell) therapy uses a patient's own immune system cells to treat acute lymphoblastic leukemia (ALL), and certain types of solid tumors.

The Nicklaus Children's Cancer & Blood Disorders Institute is an approved treatment facility to deliver the FDA approved CAR- T-cell therapy called Kymriah to children with certain types of pediatric cancers

---

Reviewed by: Jorge Galvez Silva, MD

This page was last updated on: 1/29/2019 3:21:13 PM